it would be better for patients if the supply chain was delinked from list prices

it would be better for patients if the supply chain was delinked from list prices

PBMs make more money when a drug's list price increases, while patients bear the financial burden.

High list prices hurt patients who must pay these prices. If list prices were lower, out-of-pocket payments based on list prices would be lower and more affordable.

patients would be better off if PBMs and other supply chain entities were paid flat fees

patients would be better off if PBMs and other supply chain entities were paid flat fees

pharmacy benefit managers are key players, or should be, in alleviating patients' financial burden at the pharmacy counter

this vote that we are about to take today has deep personal significance for me and for many others. For me, as chairman of the Senate Foreign Relations Committee, I finally have come full circle from my vote in the House of…

The hyper-consolidation, with little to no regulatory oversight, creates inappropriate negotiating leverage that discourages competition and makes it difficult to achieve transparency, affordability, and timely access for patients.

To have the opportunity to think about these issues with Rudy is going to be an interesting opportunity.

Under the current structure, PBMs make more money when a drug's list price increases, while patients bear the financial burden.

it is also just fascinating, because I know the area that he represents, northern Indiana.